Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Characteristics and treatment regimens across ERS SHARP severe asthma registries.

van Bragt JJMH, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, Canonica GW, Cao H, Chung KF, Csoma Z, Dahlen B, Davin E, Hansen S, Heffler E, Horvath I, Korn S, Kots M, Kuna P, Kwon N, Louis R, Plaza V, Porsbjerg C, Ramos-Barbon D, Richards LB, Skrgat S, Sont JK, Vijverberg SJH, Weersink EJ, Yasinska V, Wagers SS, Djukanovic R, Maitland-van der Zee AH; SHARP CRC.

Eur Respir J. 2019 Oct 10. pii: 1901163. doi: 10.1183/13993003.01163-2019. [Epub ahead of print]

PMID:
31601713
2.

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study.

Khurana S, Brusselle GG, Bel EH, FitzGerald JM, Masoli M, Korn S, Kato M, Albers FC, Bradford ES, Gilson MJ, Price RG, Humbert M.

Clin Ther. 2019 Aug 22. pii: S0149-2918(19)30350-9. doi: 10.1016/j.clinthera.2019.07.007. [Epub ahead of print]

3.

Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers.

Korn S, Wilk M, Voigt S, Weber S, Keller T, Buhl R.

Respiration. 2019 Jul 9:1-8. doi: 10.1159/000500727. [Epub ahead of print]

4.

LanI-Mediated Lantibiotic Immunity in Bacillus subtilis: Functional Analysis.

Geiger C, Korn SM, Häsler M, Peetz O, Martin J, Kötter P, Morgner N, Entian KD.

Appl Environ Microbiol. 2019 May 16;85(11). pii: e00534-19. doi: 10.1128/AEM.00534-19. Print 2019 Jun 1.

PMID:
30952662
5.

Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.

D'Andrea D, Soria F, Zehetmayer S, Gust KM, Korn S, Witjes JA, Shariat SF.

BJU Int. 2019 Jun;123(6):959-967. doi: 10.1111/bju.14673. Epub 2019 Feb 5.

PMID:
30653818
6.

Role of lasers in urology.

Korn SM, Hübner NA, Seitz C, Shariat SF, Fajkovic H.

Photochem Photobiol Sci. 2019 Feb 13;18(2):295-303. doi: 10.1039/c8pp00409a. Review.

PMID:
30640321
7.

The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.

Djukanovic R, Adcock IM, Anderson G, Bel EH, Canonica GW, Cao H, Chung KF, Davies DE, Genton C, Gibson-Latimer T, Hamerlijnck D, Heuvelin E, Louis R, Korn S, Kots M, Kwon N, Naddaf R, Wagers SS; SHARP Clinical Research Collaboration; Members of the CRC-SHARP.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801671. doi: 10.1183/13993003.01671-2018. Print 2018 Nov. No abstract available.

PMID:
30498052
8.

Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.

Busse WW, Brusselle GG, Korn S, Kuna P, Magnan A, Cohen D, Bowen K, Piechowiak T, Wang MM, Colice G.

Eur Respir J. 2019 Jan 31;53(2). pii: 1800948. doi: 10.1183/13993003.00948-2018. Print 2019 Feb.

PMID:
30442714
9.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):e3. doi: 10.1055/a-0790-0021. Epub 2018 Nov 7. German. No abstract available.

PMID:
30406626
10.

Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.

Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):589-596.e3. doi: 10.1016/j.jaip.2018.08.021. Epub 2018 Sep 5.

PMID:
30193936
11.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupold A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):e2. doi: 10.1055/s-0044-100881. Epub 2018 Jan 15. German. No abstract available.

PMID:
29334688
12.

Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.

Hesse L, van Ieperen N, Habraken C, Petersen AH, Korn S, Smilda T, Goedewaagen B, Ruiters MH, van der Graaf AC, Nawijn MC.

Allergy. 2018 Apr;73(4):862-874. doi: 10.1111/all.13382. Epub 2018 Jan 31.

13.

[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V; Deutsche Gesellschaft für Rehabilitationswissenschaften e.V; und Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V.;, Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.

Pneumologie. 2017 Dec;71(12):849-919. doi: 10.1055/s-0043-119504. Epub 2017 Dec 7. German. Erratum in: Pneumologie. 2017 Dec;71(12 ):e2. Taube, R C [corrected to Taube, C]. Pneumologie. 2017 Dec;71(12):e3.

14.

68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making.

Grubmüller B, Baltzer P, D'Andrea D, Korn S, Haug AR, Hacker M, Grubmüller KH, Goldner GM, Wadsak W, Pfaff S, Babich J, Seitz C, Fajkovic H, Susani M, Mazal P, Kramer G, Shariat SF, Hartenbach M.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):235-242. doi: 10.1007/s00259-017-3858-2. Epub 2017 Oct 26.

15.

Characteristics and clinical significance of histological variants of bladder cancer.

Moschini M, D'Andrea D, Korn S, Irmak Y, Soria F, Compérat E, Shariat SF.

Nat Rev Urol. 2017 Nov;14(11):651-668. doi: 10.1038/nrurol.2017.125. Epub 2017 Sep 12. Review.

PMID:
28895563
16.

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.

Pavord ID, Chanez P, Criner GJ, Kerstjens HAM, Korn S, Lugogo N, Martinot JB, Sagara H, Albers FC, Bradford ES, Harris SS, Mayer B, Rubin DB, Yancey SW, Sciurba FC.

N Engl J Med. 2017 Oct 26;377(17):1613-1629. doi: 10.1056/NEJMoa1708208. Epub 2017 Sep 11.

17.

Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy.

Moschini M, Soria F, Susani M, Korn S, Briganti A, Roupret M, Seitz C, Gust K, Haitel A, Montorsi F, Wirth G, Robinson BD, Karakiewicz PI, Özsoy M, Rink M, Shariat SF.

Bladder Cancer. 2017 Jul 27;3(3):161-169. doi: 10.3233/BLC-160086.

18.

Specificity of Subtilin-Mediated Activation of Histidine Kinase SpaK.

Geiger C, Spieß T, Korn SM, Kötter P, Entian KD.

Appl Environ Microbiol. 2017 Aug 31;83(18). pii: e00781-17. doi: 10.1128/AEM.00781-17. Print 2017 Sep 15.

19.

The antimicrobial spectrum of Xeroform®.

Barillo DJ, Barillo AR, Korn S, Lam K, Attar PS.

Burns. 2017 Sep;43(6):1189-1194. doi: 10.1016/j.burns.2016.10.023. Epub 2017 Jun 19.

PMID:
28641915
20.

How to optimally manage elderly bladder cancer patients?

Soria F, Moschini M, Korn S, Shariat SF.

Transl Androl Urol. 2016 Oct;5(5):683-691. Review.

21.

The long-term mental health impact of peacekeeping: prevalence and predictors of psychiatric disorder.

Forbes D, O'Donnell M, Brand RM, Korn S, Creamer M, McFarlane AC, Sim MR, Forbes AB, Hawthorne G.

BJPsych Open. 2016 Jan 20;2(1):32-37. eCollection 2016 Jan.

22.

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.

FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkström V, Aurivillius M, Goldman M; CALIMA study investigators.

Lancet. 2016 Oct 29;388(10056):2128-2141. doi: 10.1016/S0140-6736(16)31322-8. Epub 2016 Sep 5.

PMID:
27609406
23.

Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?

Mathieu R, Korn SM, Bensalah K, Kramer G, Shariat SF.

World J Urol. 2017 Apr;35(4):567-577. doi: 10.1007/s00345-016-1906-3. Epub 2016 Aug 8. Review.

PMID:
27502935
24.

Assessing biomarkers in a real-world severe asthma study (ARIETTA).

Buhl R, Korn S, Menzies-Gow A, Aubier M, Chapman KR, Canonica GW, Picado C, Martin N, Escobar RA, Korom S, Hanania NA.

Respir Med. 2016 Jun;115:7-12. doi: 10.1016/j.rmed.2016.04.001. Epub 2016 Apr 14.

25.

The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline.

Karch A, Vogelmeier C, Welte T, Bals R, Kauczor HU, Biederer J, Heinrich J, Schulz H, Gläser S, Holle R, Watz H, Korn S, Adaskina N, Biertz F, Vogel C, Vestbo J, Wouters EF, Rabe KF, Söhler S, Koch A, Jörres RA; COSYCONET Study Group.

Respir Med. 2016 May;114:27-37. doi: 10.1016/j.rmed.2016.03.008. Epub 2016 Mar 11.

26.

GARP inhibits allergic airway inflammation in a humanized mouse model.

Meyer-Martin H, Hahn SA, Beckert H, Belz C, Heinz A, Jonuleit H, Becker C, Taube C, Korn S, Buhl R, Reuter S, Tuettenberg A.

Allergy. 2016 Sep;71(9):1274-83. doi: 10.1111/all.12883. Epub 2016 Apr 1.

PMID:
26990894
27.

The Solution Structure of the Lantibiotic Immunity Protein NisI and Its Interactions with Nisin.

Hacker C, Christ NA, Duchardt-Ferner E, Korn S, Göbl C, Berninger L, Düsterhus S, Hellmich UA, Madl T, Kötter P, Entian KD, Wöhnert J.

J Biol Chem. 2015 Nov 27;290(48):28869-86. doi: 10.1074/jbc.M115.679969. Epub 2015 Oct 12.

28.

Non-hip and non-vertebral fractures: the neglected fracture sites.

Holloway KL, Henry MJ, Brennan-Olsen SL, Bucki-Smith G, Nicholson GC, Korn S, Sanders KM, Pasco JA, Kotowicz MA.

Osteoporos Int. 2016 Mar;27(3):905-913. doi: 10.1007/s00198-015-3322-8. Epub 2015 Oct 5.

PMID:
26438309
29.

Autoinduction Specificities of the Lantibiotics Subtilin and Nisin.

Spieß T, Korn SM, Kötter P, Entian KD.

Appl Environ Microbiol. 2015 Nov;81(22):7914-23. doi: 10.1128/AEM.02392-15. Epub 2015 Sep 4.

30.

Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.

Brightling CE, Chanez P, Leigh R, O'Byrne PM, Korn S, She D, May RD, Streicher K, Ranade K, Piper E.

Lancet Respir Med. 2015 Sep;3(9):692-701. doi: 10.1016/S2213-2600(15)00197-6. Epub 2015 Jul 28.

PMID:
26231288
31.

Humeral Fractures in South-Eastern Australia: Epidemiology and Risk Factors.

Holloway KL, Bucki-Smith G, Morse AG, Brennan-Olsen SL, Kotowicz MA, Moloney DJ, Sanders KM, Korn S, Timney EN, Dobbins AG, Pasco JA.

Calcif Tissue Int. 2015 Nov;97(5):453-65. doi: 10.1007/s00223-015-0039-9. Epub 2015 Jul 14.

PMID:
26169198
32.

Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.

Ferguson GT, Fležar M, Korn S, Korducki L, Grönke L, Abrahams R, Buhl R.

Adv Ther. 2015 Jun;32(6):523-36. doi: 10.1007/s12325-015-0218-0. Epub 2015 Jun 26.

33.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. Erratum in: N Engl J Med. 2015 Aug 6;373(6):586.

34.

Activation of Histidine Kinase SpaK Is Mediated by the N-Terminal Portion of Subtilin-Like Lantibiotics and Is Independent of Lipid II.

Spieß T, Korn SM, Kötter P, Entian KD.

Appl Environ Microbiol. 2015 Aug 15;81(16):5335-43. doi: 10.1128/AEM.01368-15. Epub 2015 May 29.

35.

Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.

Krug N, Hohlfeld JM, Kirsten AM, Kornmann O, Beeh KM, Kappeler D, Korn S, Ignatenko S, Timmer W, Rogon C, Zeitvogel J, Zhang N, Bille J, Homburg U, Turowska A, Bachert C, Werfel T, Buhl R, Renz J, Garn H, Renz H.

N Engl J Med. 2015 May 21;372(21):1987-95. doi: 10.1056/NEJMoa1411776. Epub 2015 May 17.

36.

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.

Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O'Brien C, Korn S.

Lancet Respir Med. 2015 May;3(5):355-66. doi: 10.1016/S2213-2600(15)00042-9. Epub 2015 Feb 23. Erratum in: Lancet Respir Med. 2015 Apr;3(4):e15. Lancet Respir Med. 2016 Oct;4(10 ):e50.

PMID:
25736990
37.

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.

Buhl R, Gessner C, Schuermann W, Foerster K, Sieder C, Hiltl S, Korn S.

Thorax. 2015 Apr;70(4):311-9. doi: 10.1136/thoraxjnl-2014-206345. Epub 2015 Feb 12.

38.

NMR resonance assignments of the lantibiotic immunity protein NisI from Lactococcus lactis.

Hacker C, Christ NA, Duchardt-Ferner E, Korn S, Berninger L, Kötter P, Entian KD, Wöhnert J.

Biomol NMR Assign. 2015 Oct;9(2):293-7. doi: 10.1007/s12104-015-9595-1. Epub 2015 Jan 23.

PMID:
25613223
39.

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study.

Singh D, Jones PW, Bateman ED, Korn S, Serra C, Molins E, Caracta C, Gil EG, Leselbaum A.

BMC Pulm Med. 2014 Nov 18;14:178. doi: 10.1186/1471-2466-14-178.

40.

Protective effects of Ginkgo biloba extract EGb 761 against noise trauma-induced hearing loss and tinnitus development.

Tziridis K, Korn S, Ahlf S, Schulze H.

Neural Plast. 2014;2014:427298. doi: 10.1155/2014/427298. Epub 2014 Jun 17.

41.

Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.

Beeh KM, Moroni-Zentgraf P, Ablinger O, Hollaenderova Z, Unseld A, Engel M, Korn S.

Respir Res. 2014 Jun 3;15:61. doi: 10.1186/1465-9921-15-61.

42.

Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.

Beeh KM, Korn S, Beier J, Jadayel D, Henley M, D'Andrea P, Banerji D.

Respir Med. 2014 Apr;108(4):584-92. doi: 10.1016/j.rmed.2014.01.006. Epub 2014 Jan 21.

43.

[Disease modification and duration of omalizumab treatment in patients with severe allergic asthma].

Schreiber J, Kopp MV, Korn S, Taube C, Buhl R.

Pneumologie. 2014 Mar;68(3):187-92. doi: 10.1055/s-0033-1359242. Epub 2014 Jan 29. Review. German.

44.

Against all odds: anti-IgE for intrinsic asthma?

Lommatzsch M, Korn S, Buhl R, Virchow JC.

Thorax. 2014 Jan;69(1):94-6. doi: 10.1136/thoraxjnl-2013-203738. Epub 2013 May 24.

45.

Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency.

Korn S, Hübner M, Jung M, Blettner M, Buhl R.

Respir Res. 2013 Feb 22;14:25. doi: 10.1186/1465-9921-14-25.

46.

Population norms for the AQoL derived from the 2007 Australian National Survey of Mental Health and Wellbeing.

Hawthorne G, Korn S, Richardson J.

Aust N Z J Public Health. 2013 Feb;37(1):7-16. doi: 10.1111/1753-6405.12004.

PMID:
23379800
47.

The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumab.

Strohner P, Korn S, Buhl R, Becher G.

J Immunoassay Immunochem. 2013;34(1):83-93. doi: 10.1080/15321819.2012.683501.

PMID:
23323984
48.

Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.

Decramer M, Dahl R, Kornmann O, Korn S, Lawrence D, McBryan D.

Respir Med. 2013 Feb;107(2):223-32. doi: 10.1016/j.rmed.2012.10.022. Epub 2012 Dec 6.

49.

Predisposition for and prevention of subjective tinnitus development.

Ahlf S, Tziridis K, Korn S, Strohmeyer I, Schulze H.

PLoS One. 2012;7(10):e44519. doi: 10.1371/journal.pone.0044519. Epub 2012 Oct 2.

50.

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P.

Lancet. 2012 Aug 18;380(9842):651-9. doi: 10.1016/S0140-6736(12)60988-X.

PMID:
22901886

Supplemental Content

Support Center